Logo image of ACTG

ACACIA RESEARCH CORP (ACTG) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ACTG - US0038813079 - Common Stock

3.76 USD
+0.03 (+0.8%)
Last: 12/9/2025, 4:30:00 PM
3.76 USD
0 (0%)
After Hours: 12/9/2025, 4:30:00 PM
Fundamental Rating

4

ACTG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 97 industry peers in the Financial Services industry. The financial health of ACTG is average, but there are quite some concerns on its profitability. ACTG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ACTG had positive earnings in the past year.
ACTG had a positive operating cash flow in the past year.
In multiple years ACTG reported negative net income over the last 5 years.
In multiple years ACTG reported negative operating cash flow during the last 5 years.
ACTG Yearly Net Income VS EBIT VS OCF VS FCFACTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.68%, ACTG is doing worse than 60.82% of the companies in the same industry.
The Return On Equity of ACTG (0.98%) is worse than 69.07% of its industry peers.
The Return On Invested Capital of ACTG (1.01%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.68%
ROE 0.98%
ROIC 1.01%
ROA(3y)-7.87%
ROA(5y)1.65%
ROE(3y)-15.04%
ROE(5y)2.47%
ROIC(3y)N/A
ROIC(5y)N/A
ACTG Yearly ROA, ROE, ROICACTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Profit Margin of ACTG (1.85%) is worse than 67.01% of its industry peers.
ACTG has a worse Operating Margin (3.23%) than 67.01% of its industry peers.
The Gross Margin of ACTG (41.82%) is better than 61.86% of its industry peers.
In the last couple of years the Gross Margin of ACTG has declined.
Industry RankSector Rank
OM 3.23%
PM (TTM) 1.85%
GM 41.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.92%
GM growth 5Y-5.27%
ACTG Yearly Profit, Operating, Gross MarginsACTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACTG is destroying value.
The number of shares outstanding for ACTG has been reduced compared to 1 year ago.
Compared to 5 years ago, ACTG has more shares outstanding
Compared to 1 year ago, ACTG has a worse debt to assets ratio.
ACTG Yearly Shares OutstandingACTG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ACTG Yearly Total Debt VS Total AssetsACTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ACTG has an Altman-Z score of 1.51. This is a bad value and indicates that ACTG is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ACTG (1.51) is better than 67.01% of its industry peers.
The Debt to FCF ratio of ACTG is 3.39, which is a good value as it means it would take ACTG, 3.39 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ACTG (3.39) is better than 68.04% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that ACTG is not too dependend on debt financing.
The Debt to Equity ratio of ACTG (0.17) is better than 67.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 3.39
Altman-Z 1.51
ROIC/WACC0.12
WACC8.44%
ACTG Yearly LT Debt VS Equity VS FCFACTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ACTG has a Current Ratio of 8.63. This indicates that ACTG is financially healthy and has no problem in meeting its short term obligations.
ACTG has a better Current ratio (8.63) than 96.91% of its industry peers.
ACTG has a Quick Ratio of 8.11. This indicates that ACTG is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 8.11, ACTG belongs to the best of the industry, outperforming 96.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.63
Quick Ratio 8.11
ACTG Yearly Current Assets VS Current LiabilitesACTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

ACTG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -92.65%.
Looking at the last year, ACTG shows a very strong growth in Revenue. The Revenue has grown by 71.28%.
ACTG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 61.31% yearly.
EPS 1Y (TTM)-92.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
Revenue 1Y (TTM)71.28%
Revenue growth 3Y11.6%
Revenue growth 5Y61.31%
Sales Q2Q%155.02%

3.2 Future

Based on estimates for the next years, ACTG will show a very negative growth in Earnings Per Share. The EPS will decrease by -167.21% on average per year.
Based on estimates for the next years, ACTG will show a quite strong growth in Revenue. The Revenue will grow by 18.43% on average per year.
EPS Next Y151%
EPS Next 2Y-167.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year125.31%
Revenue Next 2Y18.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ACTG Yearly Revenue VS EstimatesACTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
ACTG Yearly EPS VS EstimatesACTG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 0 2 -2

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 75.20 indicates a quite expensive valuation of ACTG.
ACTG's Price/Earnings ratio is a bit more expensive when compared to the industry. ACTG is more expensive than 74.23% of the companies in the same industry.
When comparing the Price/Earnings ratio of ACTG to the average of the S&P500 Index (26.34), we can say ACTG is valued expensively.
The Forward Price/Earnings Ratio is negative for ACTG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 75.2
Fwd PE N/A
ACTG Price Earnings VS Forward Price EarningsACTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACTG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
ACTG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ACTG is cheaper than 64.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.54
EV/EBITDA 0.68
ACTG Per share dataACTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACTG's earnings are expected to decrease with -167.21% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y-167.21%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACTG!.
Industry RankSector Rank
Dividend Yield N/A

ACACIA RESEARCH CORP

NASDAQ:ACTG (12/9/2025, 4:30:00 PM)

After market: 3.76 0 (0%)

3.76

+0.03 (+0.8%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-11 2026-03-11/amc
Inst Owners88.85%
Inst Owner Change0.54%
Ins Owners1.24%
Ins Owner Change-0.65%
Market Cap375.57M
Revenue(TTM)283.95M
Net Income(TTM)5.26M
Analysts82.86
Price Target5.1 (35.64%)
Short Float %1.53%
Short Ratio8.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.69%
Min EPS beat(2)50.98%
Max EPS beat(2)80.39%
EPS beat(4)3
Avg EPS beat(4)142.07%
Min EPS beat(4)-71.57%
Max EPS beat(4)508.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)22.35%
Min Revenue beat(2)-8.67%
Max Revenue beat(2)53.37%
Revenue beat(4)3
Avg Revenue beat(4)41.67%
Min Revenue beat(4)-8.67%
Max Revenue beat(4)121.79%
Revenue beat(8)6
Avg Revenue beat(8)165.85%
Revenue beat(12)7
Avg Revenue beat(12)107.07%
Revenue beat(16)10
Avg Revenue beat(16)153.75%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)150%
EPS NY rev (3m)150%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)8.52%
Revenue NY rev (3m)8.52%
Valuation
Industry RankSector Rank
PE 75.2
Fwd PE N/A
P/S 1.32
P/FCF 13.54
P/OCF 8.92
P/B 0.7
P/tB 0.82
EV/EBITDA 0.68
EPS(TTM)0.05
EY1.33%
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)0.28
FCFY7.38%
OCF(TTM)0.42
OCFY11.21%
SpS2.84
BVpS5.38
TBVpS4.57
PEG (NY)0.5
PEG (5Y)N/A
Graham Number2.46
Profitability
Industry RankSector Rank
ROA 0.68%
ROE 0.98%
ROCE 1.28%
ROIC 1.01%
ROICexc 2.06%
ROICexgc 2.67%
OM 3.23%
PM (TTM) 1.85%
GM 41.82%
FCFM 9.77%
ROA(3y)-7.87%
ROA(5y)1.65%
ROE(3y)-15.04%
ROE(5y)2.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.92%
GM growth 5Y-5.27%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 3.39
Debt/EBITDA 1.74
Cap/Depr 31.99%
Cap/Sales 5.06%
Interest Coverage 250
Cash Conversion 77.87%
Profit Quality 526.79%
Current Ratio 8.63
Quick Ratio 8.11
Altman-Z 1.51
F-Score5
WACC8.44%
ROIC/WACC0.12
Cap/Depr(3y)189.58%
Cap/Depr(5y)211.52%
Cap/Sales(3y)49.19%
Cap/Sales(5y)43.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
EPS Next Y151%
EPS Next 2Y-167.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)71.28%
Revenue growth 3Y11.6%
Revenue growth 5Y61.31%
Sales Q2Q%155.02%
Revenue Next Year125.31%
Revenue Next 2Y18.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-81.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year375.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y166.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y200.94%
OCF growth 3Y55.62%
OCF growth 5YN/A

ACACIA RESEARCH CORP / ACTG FAQ

What is the fundamental rating for ACTG stock?

ChartMill assigns a fundamental rating of 4 / 10 to ACTG.


What is the valuation status for ACTG stock?

ChartMill assigns a valuation rating of 3 / 10 to ACACIA RESEARCH CORP (ACTG). This can be considered as Overvalued.


Can you provide the profitability details for ACACIA RESEARCH CORP?

ACACIA RESEARCH CORP (ACTG) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for ACTG stock?

The Price/Earnings (PE) ratio for ACACIA RESEARCH CORP (ACTG) is 75.2 and the Price/Book (PB) ratio is 0.7.


How financially healthy is ACACIA RESEARCH CORP?

The financial health rating of ACACIA RESEARCH CORP (ACTG) is 6 / 10.